LeMaitre Vascular, Inc. (LMAT) Social Stream
Lemaitre Vascular Inc (LMAT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Lemaitre Vascular Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
LMAT's average price target has moved down $6.05 over the prior 46 weeks.
LMAT reports an average of 15.28% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
LMAT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
LMAT's average broker recommendation rating improved by 0 over the prior 28 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Lemaitre Vascular Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than 186.96% of that group.
- LMAT has a greater average analyst price target than 645% of stocks in the small market cap category.
- Lemaitre Vascular Inc's upside potential (average analyst target price relative to current price) is greater than 147.1% of Healthcare stocks.
- In the context of Healthcare stocks, Lemaitre Vascular Inc's variance in analysts' estimates is lower than -94.22% of them.
What is the outlook for LMAT? Use POWR Ratings for clearer insight into price direction.